NAMS

NewAmsterdam Pharma Co N.V.

Pharmaceutical Preparations · SIC 2834CIK 1936258Held by 9 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

9 managers · Q2 2026 13F

13F bookWeight

RA Capital Management

RA Capital ManagementPosition history →

2.8%

—

$323.7M

$11.51B13F book · 2026-06-30

Duquesne Family Office

Stanley DruckenmillerPosition history →

2.4%

—

$104.0M

$4.35B13F book · 2026-06-30

Deerfield Management Company

Deerfield Management CompanyPosition history →

1.5%

—

$144.5M

$9.59B13F book · 2026-06-30

Maverick Capital

Lee AinsliePosition history →

1.00%

+49.5%

$110.7M

$11.08B13F book · 2026-06-30

Viking Global Investors

Andreas HalvorsenPosition history →

0.41%

—

$142.5M

$35.08B13F book · 2026-06-30

Orbis Investment Management

Orbis Investment ManagementPosition history →

0.20%

NEW

$59.2M

$29.10B13F book · 2026-06-30

Capital World Investors

Capital World InvestorsPosition history →

0.05%

+10.1%

$414.5M

$846.43B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.03%

(50.3%)

$18.6M

$71.32B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

0.02%

+26.2%

$4.0M

$21.33B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.